Stocks
Chemed Corporation Financial Statements (CHE) |
||||||||||
| Chemed Corporationsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 26.02.2020 | 26.02.2021 | 28.02.2022 | 27.02.2023 | 29.02.2024 | 29.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 939 | 2 080 | 2 139 | 2 135 | 2 264 | 2 329 | |||
| Operating Income, bln rub | 257.4 | 389.7 | 343.0 | 343.5 | 342.8 | 342.9 | ||||
| EBITDA, bln rub | ? | 311.3 | 454.9 | 411.2 | 393.4 | 403.7 | 412.3 | |||
| Net profit, bln rub | ? | 219.9 | 319.5 | 268.6 | 249.6 | 272.5 | 295.0 | |||
| OCF, bln rub | ? | 301.2 | 489.3 | 308.6 | 309.9 | 330.3 | 222.0 | |||
| CAPEX, bln rub | ? | 53.0 | 58.8 | 58.7 | 57.3 | 56.9 | 35.6 | |||
| FCF, bln rub | ? | 248.2 | 430.5 | 249.9 | 252.6 | 273.4 | 186.4 | |||
| Dividend payout, bln rub | 19.8 | 21.1 | 22.0 | 22.0 | 23.5 | 18.1 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 9.00% | 6.60% | 8.20% | 8.82% | 8.62% | 6.15% | ||||
| OPEX, bln rub | 360.0 | 311.7 | 426.8 | 421.6 | 395.1 | 443.6 | ||||
| Cost of production, bln rub | 1 321 | 1 378 | 1 369 | 1 370 | 1 526 | 1 538 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 4.54 | 2.36 | 1.87 | 4.58 | 3.11 | 1.64 | ||||
| Assets, bln rub | 1 268 | 1 435 | 1 343 | 1 442 | 1 761 | 1 728 | ||||
| Net Assets, bln rub | ? | 726.6 | 901.2 | 623.3 | 798.7 | 1 108 | 1 183 | |||
| Debt, bln rub | 215.9 | 135.4 | 323.5 | 247.0 | 155.1 | 159.7 | ||||
| Cash, bln rub | 6.16 | 162.7 | 32.9 | 74.1 | 264.0 | 313.4 | ||||
| Net debt, bln rub | 209.8 | -27.3 | 290.6 | 172.9 | -108.8 | -153.6 | ||||
| Ordinary share price, rub | 439.3 | 532.6 | 529.0 | 510.4 | 584.8 | 564.5 | ||||
| Number of ordinary shares, mln | 16.0 | 16.0 | 15.7 | 14.9 | 15.1 | 15.1 | ||||
| Market cap, bln rub | 7 015 | 8 498 | 8 291 | 7 620 | 8 800 | 8 536 | ||||
| EV, bln rub | ? | 7 224 | 8 471 | 8 581 | 7 793 | 8 692 | 8 382 | |||
| Book value, bln rub | 23 | 205 | -63 | 118 | 433 | 504 | ||||
| EPS, rub | ? | 13.8 | 20.0 | 17.1 | 16.7 | 18.1 | 19.5 | |||
| FCF/share, rub | 15.5 | 27.0 | 15.9 | 16.9 | 18.2 | 12.3 | ||||
| BV/share, rub | 1.43 | 12.8 | -4.05 | 7.88 | 28.7 | 33.3 | ||||
| EBITDA margin, % | ? | 16.1% | 21.9% | 19.2% | 18.4% | 17.8% | 17.7% | |||
| Net margin, % | ? | 11.3% | 15.4% | 12.6% | 11.7% | 12.0% | 12.7% | |||
| FCF yield, % | ? | 3.54% | 5.07% | 3.01% | 3.31% | 3.11% | 2.18% | |||
| ROE, % | ? | 30.3% | 35.4% | 43.1% | 31.3% | 24.6% | 24.9% | |||
| ROA, % | ? | 17.3% | 22.3% | 20.0% | 17.3% | 15.5% | 17.1% | |||
| P/E | ? | 31.9 | 26.6 | 30.9 | 30.5 | 32.3 | 28.9 | |||
| P/FCF | 28.3 | 19.7 | 33.2 | 30.2 | 32.2 | 45.8 | ||||
| P/S | ? | 3.62 | 4.09 | 3.88 | 3.57 | 3.89 | 3.67 | |||
| P/BV | ? | 306.7 | 41.5 | -130.7 | 64.7 | 20.3 | 16.9 | |||
| EV/EBITDA | ? | 23.2 | 18.6 | 20.9 | 19.8 | 21.5 | 20.3 | |||
| Debt/EBITDA | 0.67 | -0.06 | 0.71 | 0.44 | -0.27 | -0.37 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 2.74% | 2.83% | 2.74% | 2.69% | 2.51% | 1.53% | ||||
| Chemed Corporation shareholders | ||||||||||
